How Vanderbilt is turning greater-good research into cash [From our print edition featured in Monday's City Paper]
Testing firm sues doctor who created its central technology over his departure from the company
Factory comings and goings, Lipscomb AD resigns, home sales still plunging, and more...
Cancer treatment and Vanderbilt royalties are at stake, as university tries to regain control of marketable technology
VU and Sumner investor group seek two-way flow of ideas, capital and expertise
Engineers find 'dirty bomb' in briefcase at Dudley Field: This is only a test.
All Articles